EZH2 and breast carcinoma: Highly up-regulated in breast cancer, the lncRNA HOX transcript antisense RNA (HOTAIR) mediates H3K27 tri-methylation and the epigenetic silencing of tumor suppressor genes by recruiting enhancer of zeste homolog 2 (EZH2), which is considered a key molecule and potential biomarker for breast cancer [12].